Background: Tracheal extubation is related to many side effects of hemodynamic, especially for patients with comorbid states. The study compared the validity of dexmedetomidine 1 μg/kg and low combination dose of dexmedetomidine 0.5 μg/kg plus Lidocaine 1 mg/kg in softening hemodynamic stress response and estimated quality of extubation in study groups. Materials and Methods: The patients in our study, one hundred and fifty of both gender, ASA class I &II patients, aged 20 -50 years old subject to elective abdominal operations under general anesthesia were allocated into three equal groups. Anesthetic technique was standardized. Before extubation by 10 minutes, the patients in Group N, D, and DL have given 0.9% normal Saline intravenous bolus infusion, dexmedetomidine 1 μg/kg and Dexmedetomidine 0.5 μg/kg, respectively within a 10-minute period. Before complete extubation by 90 seconds, in the three groups by syringe ten cc volumes and at time of extubation, Group N and D patients received 0.9% normal Saline intravenous bolus infusion, but in Group DL received Lidocaine 1 mg/kg then extubation completed. Heart rate (HR), Diastolic BP (DBP), Systolic BP (SBP), and Mean Arterial Pressure (MAP) were noted at baseline, at the reverse, extubation, 2, 4, 6, 8, 10 min and at the regular times after that for two hours. Extubation 112 Open Journal of Anesthesiology quality was assessed by extubation quality scale. Aldrete's recovery score and Ramsay sedation score were also recorded and also any complications were noted and recorded. Results: All the hemodynamic parameters significantly elevated extubation and numerous periods of observation in the normal saline group than dexmedetomidine and dexmedetomidine plus Lidocaine group (p-value = 0.001). Response of tachycardia was seen in 41 (82%) in patients of N group, compared to 18 (36%) and 20 (40%) in D & DL group respectively (p = 0.001). Hypertensive response statistically significant noticed in 40 (80%) patients of N group, 9 (18%) of D group and 12 (24%) of DL group (p = 0.001). Tachycardia duration and the response of hypertension were significantly prolonged in the control group. As regards extubation quality, the three groups differed in D Groups (1.93 ± 0.57) and DL (1.51 ± 0.57) had decreased scores compared to group N (2.67 ± 0.48) modulating smoother extubation (p < 0.001). As regard to Ramsay sedation score for 25 min following incoming at PACU was Groups D (2.17 ± 0.43), DL (2.07 ± 0.35) and had raised sedation scores when compared to group N (1.93 ± 0.28) (p < 0.003). Conclusion: Low combined dose of (Dexmedetomidine 0.5 μg/kg plus Lidocaine 1 mg/kg) IV was useful as much as Dexmedetomidine 1 μg/kg IV in softening hemodynamic stress responses during emergence.
Introduction
Sympathetic reflex is almost always associated with hemodynamic changes during endotracheal intubation and extubation as well. Due to stimulation of epipharyngeal and laryngopharyngealso, tracheal extubation is as challenging as intubation in anesthesia practice. These hemodynamic changes result in arrhythmias and hypertension. The elevation in heart rate and blood pressure is usually unpredictable. It is more dangerous to the patient with hypertension, myocardial insufficiency or cerebrovascular diseases [1] .
Tracheal extubation may cause cough or difficulties in breathing and may lead to an elevation in blood pressure. Respiratory complications incidences after extubation have been three times more common than during intubation that prevalence (4.6% versus 12.6%) [2] - [9] .
Smooth tracheal extubation results in the absence of straining, movement, coughing, breath-holding or laryngospasm. By different techniques and available antihypertensive drugs attenuate airway and circulatory reflexes during extubation, but none have been entirely successful. Many attempts of methods have been made to decrease the pressor response by the use of many drugs such as narcotic analgesics, deep anesthesia induced by inhalational anesthetics, local anesthetics, adrenoceptor blockers, and vasodilator agents [2] .
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Additional studies have been carried out with the use of diltiazem, lignocaine, esmolol, labetalol, nicardipine, and opioids as the sole agent or in comparison with each other. Many types of research is still try to detect a perfect and typical drug with a right protective margin, which decreases nearly of the hemodynamic changes in response to airway stimulation at tracheal extubation with good quality and without delaying recovery and without causing complications (such as sedation, respiratory depression, hypotension, etc.).
To decrease airway and pressor response during tracheal extubation, dexmedetomidine, a highly selective alpha-two adrenoceptor agonist has studied as a single dose, at the time of extubation and as an anesthetic adjuvant. It's a sympatholytic effect through decreases in the concentration of norepinephrine. [3] [5]. This, in turn, decreases the heart rate (HR) and blood pressure. Dexmedetomidine, therefore, is theoretically appropriate for reducing airway and circulatory reflexes during emergence from anesthesia [6] .
Lignocaine, a local amide anesthetic, injected intravenously or topically applied to larynx and trachea, is variably effective at blunting the hemodynamic response to tracheal stimulation. Lignocaine also has been used to decrease these reflexes during extubation [10] [11] . It attenuates the hemodynamic response to tracheal extubation by its direct myocardial depressant effect, central stimulant effect, peripheral vasodilatory effect, and finally, it suppresses the cough reflex, an effect on synaptic transmission [12] . It also prevents the rise in intracranial pressure associated with tracheal suctioning and may to avoid the increase in intraocular pressure seen with tracheal extubation. It also decreases intracellular calcium concentration in airway smooth muscle, decreases myofilament calcium sensitivity and that cause prevents reflex bronchoconstriction and suppresses the cough reflex [10] [11] .
As the pharmacological mechanism controlling the hemodynamic changes during extubation is different between dexmedetomidine and lidocaine, the concomitant use of these drugs may enhance the prophylactic effect of each drug alone for this purpose [12] . Therefore, our study was designed to compare the efficacy of low dose of dexmedetomidine plus lidocaine with stander dose of dexmedetomidine (1 μg/kg) alone in suppressing the hemodynamic changes and catecholamine responses during extubation in abdominal surgery.
The aim of this study is reasonable to have rapid emergence and extubation without any adverse hemodynamic and airway changes in abdominal surgery with less sedation and high extubation quality [2] .
Hence, We proceeded a prospective randomized controlled clinical trial with the primary target for assessment of the efficacy of dexmedetomidine (1 μg/kg) as standardized dose and low combined dose of (dexmedetomidine 0.5 μg/kg plus Lidocaine 1 mg/kg) respectively IV for attenuating stress response and compared extubation quality score in all study groups under equally standard anesthetic condition by applying the entropy and nerve stimulator. We also estimated quality recovery score, sedation score and other side effects amongst the three groups in the PACU over 2 hours. Open Journal of Anesthesiology 
Exclusion Criteria
Patients were with renal impairment (serum creatinine more than 1.5 mg/dl), cardiorespiratory abnormalities (bronchial asthma, COPD, and restrictive lung disease, Hypertension, New York Heart Association heart failure grades III and IV), and liver dysfunction. Significant obesity (body mass index more than 35), patients with a difficult air way, and emergency procedures were excluded from the study.
Sample Size Calculation
The sample size was estimated based on previous research that studied the influence of dexmedetomidine on extubation response directed by D Jain and coworkers, [13] who observed an elevation in Systolic Blood Pressure of 32.3 ± 11 mmHg in the control group during extubation. We created that a 20% decrease in extubation stress response in the study drug group should be clinically significant. The group size was detected by using the sample size detection "for two groups means method" with 1% significance and 90% power, based on which, we needed to study 43 patients in each group. So we added 10% compensation for "loss to follow up" and for the inclusion of a group three into our study. We obtain 50 patients in each group.
Randomization
Randomization was done by a computer-generated random number (created using Microsoft Excel 2003 software, Redmond, WA). The patients were randomized into three groups, with 50 patients in each group. Groups N, D, and DL were given intravenous bolus infusion (over 10 minutes) of 0.9% Normal Saline, 1 μg/kg Dexmedetomidine and low combination dose of dexmedetomidine 0.5 μg/kg, plus Lidocaine1 mg/kg respectively, 10 minutes before extubation.
Intraoperative Period
As the standard monitors (Electrocardiography (ECG), pulse oximetry, non-invasive blood pressure, and temperature monitoring), nerve stimulators TOF-watch were used during the intraoperative period. Before induction heart rate (HR), diastolic blood pressure (DBP), systolic blood pressure (SBP), mean arterial blood pressure (MAP) and oxygen saturation was noted.
After pre-oxygenation for 3 minutes, the induction was with intravenous fen- Any reversed events as elevated blood pressure, increase heart rate, drop in blood pressure, decrease in heart rate (<30% of baseline value), desaturation, bronchospasm was noted and managed accordingly. Open Journal of Anesthesiology Statistical analysis was done using SPSS version 15. Data were presented as Mean (SD) or number (%). The qualitative data were compared by applying Chi-Square or Fisher's exact test. The quantitative data were analyzed by using one-way ANOVA followed by post hoc comparison by Bonferroni method. To see the change over time, repeated measure analysis was applied followed by post hoc comparison by least square deviation method separately for each group. Statistical significance was accepted when p-value at P < 0.05.
Results
The total 150 patients randomly were sectioned into three groups 50 for each, re- 
Hemodynamic Parameters
Baseline value: Haemodynamic variables such as Heart Rate (HR), Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), and Mean Blood Pressure (MAP) measured before using of study drug, after discontinuation of is of lurane. The three groups were well compared concerning baseline HR, SBP, DBP, and MAP.
Heart Rate
Extreme heart rate (HR) recorded in Group N was 109 ± 11 beat per min., which was significantly higher when compared to the other two groups (p = 0.001).
The average elevation in HR above baseline noticed in group N (33 ± 10 bpm) was considerably more (p = 0.001). Tachycardia response was seen in 82% of patients in group N, compared to 36% and 40% in group D & DL respectively 
Systolic Blood Pressure
Maximum Systolic Blood Pressure observed in group N, D and DL were 158 ± 14, 132 ± 17 and 135 ± 8 mmHg which was statistically significant (p = 0.001). Statistically significant Hypertensive response noticed in 40 (80%) patients of group N, 9 (18%) of group D and 12 (24%) of group DL (p = 0.001). The average duration of hypertension also remained significantly highest in group N (p < 0.05) (Table 3, Figure 3 ).
Diastolic Blood Pressure
Maximum rise in Diastolic Blood Pressure in groups N, D, and DL was 89 ± 12, 79 ± 7 and 82 ± 7 mmHg respectively, which was statistically significant (p = Open Journal of Anesthesiology 
Mean Arterial Blood Pressure
The extreme value of Mean Arterial Pressure observed in groups N, D, and DL were 111 ± 12, 98 ± 8 and 99 ± 70 mmHg respectively (p-value). The maximum of elevation above baseline in groups N, D, and DL was 28 ± 11 (33%), 12 ± 8 (14%), and 13 ± 7 (16%) mmHg respectively which was statistically significant. (p = 0.001) ( Table 5 , Figure 5 ).
Recovery Profile
The minimal the extubation quality scale, the smoother was the extubation. Overall extubation quality the groups differed (p < 0.001). Groups D (1.93 ± 0.57) and DL (1.51 ± 0.57) decreased scores compared to group N (2.67 ± 0.48) implying softer extubation. Among group D and DL, group DL had best extubation quality ( Figure 6 ).
There was a significant difference among the groups as regards to Ramsay sedation score (p < 0.003) for 25 min after arrival at Post Anesthesia Care Unite.
Groups D (2.17 ± 0.43) DL (2.07 ± 0.35) and had higher sedation scores compared to group N (1.93 ± 0.28). During the latter part of the observation, there
were no statistically and clinically significant changes among study groups (Figure 7 ).
Discussion
Laryngoscopy, endotracheal intubation, and extubation are considered to be the most critical events during general anesthesia. They trigger a transient but marked sympathetic response. The resulting hemodynamic pressure response has been a constant problem for anesthesiologists. Tracheal extubation is associated with similar problems as occurring during intubation. During extubation, increased heart rate and blood pressure may result in complications such as cardiac failure, pulmonary edema, and cerebral vascular hemorrhage. [18] The proposed mechanism behind these hemodynamic changes is increased sympathetic activity and release of catecholamines.
Alpha-2 adrenergic drugs, such as dexmedetomidine or clonidine attenuate these potentially adverse events during induction of anesthesia [19] [20]. The target of this study, we compared stander dexmedetomidine single dose 1 μg/kg, a newer α-2 agonist with a low single combined dose of (dexmedetomidine 0.5 μg/kg plus Lidocaine 1 mg/kg) for attenuating hemodynamic response to tracheal extubation.
Dexmedetomidine is the alpha-2 agonist, a sedative and analgesic, reduces blood pressure and heart rate dose-dependently. Coworkers and Guler G [21] evaluated single-dose dexmedetomidine 1 μg/kg in attenuating circulatory ref-
lexes and airway reflexes during extubation. They concluded that a single-dose bolus injection of dexmedetomidine when given before extubation by 5 minutes leading to decrease of airway-circulatory reflexes without extending the recovery. Also, Recep Aksu et al. [22] have found that a single-dose bolus injection of dexmedetomidine 0.5 μg/kg IV, when given before tracheal extubation, Open Journal of Anesthesiology extubation with an increased incidence of hypotension, bradycardia, and a higher level of postoperative sedation score. [26] . In our study, dexmedetomidine (1 μg/kg) was satisfactory enough to reduce Heart Rate (HR) and blood pressure during extubation without any incidence of bradycardia, hypotension and excessive postoperative sedation. When Turan et al. [15] and Guler et al. [28] used dexmedetomidine 0.5 μg/kg over 60 s5 min before the end of the surgery to attenuate the airway reflexes and the hemodynamic during extubation, and they found Mean Arterial Pressure (MAP) and Heart Rate (HR) were significantly higher in the placebo group (control group) (P < 0.05) than the dexmedetomidine group . These results were in agreement with the outcome of our study.
In our study, the control group, HR, DBP, SBP, and MAP were significantly increased at the peri-extubation period and after that (p < 0.003). Despite decreased hemodynamic parameters after extubation, none of the patients in the D and DL groups required any clinical intervention. Changes in HR, SBP, DBP, and MAP like maximum increase, the magnitude of improvement, number of patients having values ≥ 30% above baseline and duration of this increased episode were more in control group when compared to D and DL group. Tachycardia response was observed in 82% of the control group compared to 36% of the dexmedetomidine group and 40% of dexmedetomidine plus lidocaine group (p = 0.001). The hypertensive response was observed in 80% of patients in the control group compared to 18% in the dexmedetomidine group and 24% in dexmedetomidine plus lidocaine group which was statistically significant (p = 0.001). Hypertensive response (p = 0.032) and duration of tachycardia (p = 0.001) were higher in the control group compared to other two groups.
Lignocaine also has been used to decrease these reflexes during extubation [7] [8] . It attenuates the hemodynamic response to tracheal extubation by its direct myocardial depressant effect, central stimulant effect, peripheral vasodilatory effect, and finally, it suppresses the cough reflex, an impact on synaptic transmission [12] .
As the pharmacological mechanism controlling the hemodynamic changes during extubation is different between dexmedetomidine and lidocaine, the concomitant use of these drugs may enhance the protective effect of each drug alone for this purpose. Therefore, our study was designed to compare the efficacy of low dose of dexmedetomidine plus lidocaine with dexmedetomidine alone in suppressing the hemodynamic changes and catecholamine responses during extubation in abdominal surgery.
We have used extubation quality scale, which is assessed by a 5 point where score 1 implies smooth extubation and rating of 5 was reduced. The average extubation quality in groups N, D and DL were 2.67, 1.93 and 1.51 respectively.
Dexmedetomidine plus lidocaine group had smoother extubation quality than Dexmedetomidine alone group.
During the latter part of the observation, the sedation score was comparable, and none of the patients in any group needed for any clinical intervention apart from routine post-operative monitoring. Aldrete's recovery score [10] [29] was used to detect the recovery and readiness for discharge from the post-anesthesia care unit (PACU) which was similar in the three groups studied.
Park and Jee had compared the effect of 2% lignocaine in a dose of 1 mg/kg given endotracheal and intravenously 5 min and 3 min before extubation, respectively. In the results, when lignocaine given endotracheally was better than the IV lignocaine in attenuating airway circulatory reflexes during extubation [10] .
Dexmedetomidine had the overall reasonable control of hemodynamics, smoother extubation quality, uneventful recovery, and post-anesthesia discharge. In our study, both dexmedetomidine (1 μg/kg) and low combined dose of dexmedetomidine (5 μg/kg) plus lidocaine (1 mg/kg) respectively group were useful in mitigating this emergence stress response without prolonging recovery, but low combined dose of Dexmedetomidine (0.5 μg/kg plus Lidocaine 1 mg/kg) IV was helpful as much as Dexmedetomidine 1 μg/kg IV in attenuating hemodynamic stress responses during emergence. In DL group was low sedation score and high extubation quality in comparison to D group with no clinically significant differences in sedation and extubation quality.
Conclusions
Single dose of Dexmedetomidine 1 μg/kg intravenous or low combination dose of dexmedetomidine plus lidocaine 0.5 μg/kg, 1 mg/kg respectively intravenous bolus infusion administered 10 minutes before extubation was effective in attenuating hemodynamic stress response during extubation. Dexmedetomidine was efficacious compared to dexmedetomidine plus lidocaine in mitigating emergency response. Extubation quality was superior to dexmedetomidine plus lidocaine compared dexmedetomidine or control group. As regarding sedation score and recovery profile, in the DL group were low sedation score and high extubation quality in compared to D group with no clinically significant differences in sedation and extubation quality. D and DL groups had smoother and best extubation quality. Decreasing of emergence stress response should be routine than an optional entity in day to day clinical practice.
